SEROQUEL 200 mg 60 film tablet Ruhsat Bilgileri

AstraZeneca Firması

Güncelleme : 3 Temmuz 2018

7. RUHSAT SAHİBİ

AstraZeneca İlaç San. Ve Tic. Ltd. Şti Büyükdere Cad. Yapı Kredi Plaza B blok Kat 3-4 Levent -İstanbul

8.   RUHSATNUMARASI

9. İLK RUHSAT TARİHİ / RUHSAT YENİLEME TARİHİ

10. KÜB’ÜN YENİLENME TARİHİ

10.KÜB onay tarihi:

REFERANSLAR

SERM Clinical Overview, 2010- June, Shifts in Metabolic Factors. GEL locator: [CNS.000-301-989.2.0]. Clinical Overview, 2010-Feb-03, False Positive Results for Methadone and Tricyclic Antidepressants. GEL locator: [CNS.000-291-454.4.0].

SERM Clinical Overview, 2009-Dec-03, Decreased Haemoglobin. GEL locator: [CNS.000-288-813.2.0].

SERM Clinical Overview, 2010-June, Palpitations. GEL locator: [CNS.000-306-544.2.0].

SERM Clinical Overview, 2010-June, Changes in thyroid levels. GEL locator: [CNS.000-306-463.2.0].

SERM Clinical Overview, 2010-June, Dyspnea. GEL locator: [CNS.000-306-543.3.0].

SERM Clinical Overview, 2010-June, Somnambulism and other related disorders. GEL locator:

[CNS.000-306-993.3.0].

SERM Clinical Overview, 2010- April, Decreased Neutrophil Count. GEL locator: [CNS.000-302 257.2.0].

SERM Clinical Overview, 2010-June, Overdose. GEL locator: [CNS.000-306-455.3.0]. Clinical Overview, 2009-Aug-7, Updated Suicidality Values. GEL locator: [CNS.000-294-843.2.0]. SERM Clinical Overview, 2009-Dec-03-CLEARS/Cataracts. GEL locator: [CNS.000-289-074.2.0].

3

4

8